Biote (BTMD) Invested Capital (2020 - 2026)

Biote has reported Invested Capital for 7 years, with the latest figure at -$41.7 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 46.92% year-over-year to -$41.7 million; the trailing twelve-month figure through Mar 2026 stood at -$41.7 million (up 46.92% YoY), and the FY2025 full-year result was -$52.3 million, up 45.5% from the prior year.
• Invested Capital for Q1 2026 stood at -$41.7 million, up from -$52.3 million in the prior quarter.
• The five-year high for Invested Capital was $10.7 million in Q1 2022, with the low at -$135.2 million in Q2 2024.
• Average Invested Capital over 5 years is -$64.2 million, with a median of -$64.6 million recorded in 2022.
• Peak annual rise in Invested Capital reached 201.52% in 2022, while the deepest fall reached 4674.35% in 2022.
• Tracing BTMD's Invested Capital over 5 years: stood at -$52.0 million in 2022, then jumped by 41.77% to -$30.3 million in 2023, then tumbled by 216.71% to -$95.9 million in 2024, then soared by 45.5% to -$52.3 million in 2025, then increased by 20.24% to -$41.7 million in 2026.
• The last three Invested Capital figures came in at -$41.7 million (Q1 2026), -$52.3 million (Q4 2025), and -$59.2 million (Q3 2025), per Business Quant data.

Peer Comparison